Monoclonal Antibodies Market (2010 - 2015)
By: marketsandmarkets.com
Publishing Date:
March 2012
Report Code:
PH 1261
The global market for diagnostic and therapeutic market is expected to exceed $ 25 million market by the end of 2010. mAbs held the top 3 ranks among the top selling brands in 2008. Monoclonal antibodies present significant opportunities as they are targeted therapy (They impact only the diseased cells and do not harm healthy cells) unlike chemotherapy drugs. This results in reduced side effects and increased effectiveness. Cancer in one of the significant application area for mAbs. However, price correction would enable significant shift of usage from traditional chemotherapy drugs to mAbs
We will customize the research for you, in case the report listed above does not
meet with your exact requirements. Our custom research will comprehensively cover
the business information you require to help you arrive at strategic and profitable
business decisions.
Please visit http://www.marketsandmarkets.com/custom-research.asp
to specify your custom Research Requirement
